Attachment 7 Sample Client Authorization Letter.docx

DOCX document 32 KB Posted

Attached to
Renovation of Buildings 26 and 50 Roof Replacement
Solicitation number
75F40123R00088
Issued by

About this file

This document contains a sample client authorization letter and information about a related federal contract opportunity for roof renovation services. The letter is a template to be customized on a contractor's letterhead, requesting a past performance evaluation from a client be sent directly to the Food and Drug Administration (FDA) by August 14, 2023. The evaluation would support the contractor's response to Solicitation Number 75F40123R00088, issued by the FDA for roof replacement work at buildings 26 and 50 at the National Center for Toxicological Research campus in Jefferson, Arkansas. The solicitation seeks roof renovation services and emphasizes past performance as a key evaluation factor. The letter provides contact information for the FDA contracting specialist to address any questions regarding the required past performance questionnaire.

View the file

Other files

Show all 14

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

75F40123R00088 ATTACHMENT J7

SAMPLE CLIENT AUTHORIZATION LETTER

(Transfer to Company Letterhead)

Dear Client, We are currently responding to Solicitation Number 75F40123R00088 for Building 26 and 50 Roof Renovation at the U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), 3900 NCTR Road, Jefferson, Arkansas 72079.

The FDA has placed emphasis on past performance as a key source selection factor and requires that clients of entities responding to the solicitations be identified and their participation in the evaluation process be requested; therefore, enclosed is a (present and) Past Performance Evaluation Questionnaire (PPEQ) for your completion. We are requesting that you complete the questionnaire and send it directly to the Food and Drug Administration (FDA) no later than 1:00 pm central time on August 14, 2023 to Nick Sartain, Contract Specialist at nick.sartain@fda.hhs.gov.

If you have questions or require assistance regarding the attached questionnaire, please contact Nick Sartain, FDA Contract Specialist, at 870-543-7370 or at nick.sartain@fda.hhs.gov.

Thank you for your consideration and prompt response regarding this matter.

Sincerely, {Offering Entity}

File details come from the government source that posted it. Updated .